Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

NCT: NCT06185686 · RECRUITING

NCT IDNCT06185686
StatusRECRUITING
Start Date2024-07-10
Completion2027-07-31
SponsorWashington University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

With modern therapy, the survival rate for pediatric brain tumor patients has significantly improved, with over 70% of patients surviving their disease. However, this progress often comes at the cost of substantial morbidity, with cognitive deficits being the primary obstacle to independent living. Robust predictors of cognitive decline and a comprehensive understanding of the underlying mechanisms of cognitive injury remain elusive. This study will prospectively investigate alterations in brain resting state networks following radiation therapy using functional imaging. The hypothesis is that radiation therapy leads to dose-dependent alterations in functional connectivity in the networks associated with higher level cognition, ultimately leading to cognitive decline.

Frequently Asked Questions

What is Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients?

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients is a clinical trial registered under NCT06185686. Current status: RECRUITING.

What is the status of NCT06185686?

The current status of NCT06185686 (Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients) is: RECRUITING.

When did Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients start?

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients started on 2024-07-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.